Soleno Therapeutics Inc (SLNO)
R&D Expense Growth
-48.29%
Fiscal year · Period ending:
SLNO R&D Expense Growth
Latest reported-48.29%period ending
Latest reported-48.29%period ending
SLNO FY R&D Growth (YoY) (0.00% → -48.29%)
Latest values, visible window
High-resolution chart · PNG
SLNO r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -48.2907% | |
| 211.9139% | |
| 65.0115% | |
| -28.8445% | |
| -7.4943% | |
| 42.5647% | |
| 126.623% | |
| 133.9069% | |
| -40.8128% | |
| 14.2973% | |
| 102.3107% | |
| -5.7826% | |
| -3.6471% | |
| 0% |